ClinicalTrials.gg
Enrolling by invitationNCT06206954Updated Aug 6, 2026

Supporting Decisions on Lifestyle Change

An interventional study of MyHealthPath Tool and MyHealthPath Guide in Obesity, sponsored by University of Florida. Enrolling by invitation at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-06.

Sponsored by University of Florida · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
864
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 37 studies in Obesity by University of Florida — 5 open to participants now, 6 under way, none of them phase 3. Obesity · University of Florida.

Planned enrollment
Largest of 34
864 · median 55
Started
2024
with 3 others
No phase
29 of 37
5 open now
Registered
32nd of 37
by date

Among the 37 studies in Obesity by University of Florida, this one has the largest planned enrollment of the 34 interventional ones that give a count, is one of 4 that started in 2024, is one of 29 with no phase, and was the 32nd registered.

Obesity

11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.

Browse Obesity studies →

Open to participants now

5 of the 37 studies in Obesity by University of Florida are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 5 open studies →

Where they have run

Who these studies take

Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 37 studies in Obesity by University of Florida, or all of them as a file.
02

Study summary

This study will test the effects of a brief, individually tailored intervention aiming to increase initiation of comprehensive behavioral weight loss treatment on weight.

03

Conditions studied

  • Obesity

Browse trials for

Keywords

  • initiation
  • recruitment
  • engagement
  • behavioral intervention
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 or older
  • (BMI) ≥ 30 kg/m2 based on self-report body weight and height, or BMI ≥ 27-29.9 kg/m2 with a weight related comorbidity of hypertension, type 2 diabetes, pre-diabetes, dyslipidemia, or obstructive sleep apnea, gastroesophageal reflux disease, or coronary artery disease.
  • Self-report weight ≤ 375 lbs (the maximum weight that BodyTrace scales can accurately detect is 397 lbs, thus 375 lbs provides a buffer to allow detection of at least 20 lbs weight gain).
  • Has a desire to weigh less
  • Has valid email address in Electronic Health Record
  • Has an appointment scheduled with enrolled PCP about 21-28 days after electronic data pull
  • Speaks and reads English
  • Has either WiFi internet access at home or a phone or tablet with a data plan.

Exclusion criteria

Exclusion criteria

  • Currently enrolled in evidence-based comprehensive weight loss treatment
  • Pregnant or planning to become pregnant in the next 6 months
  • Currently breastfeeding (or pumping breastmilk) more than 3 times per day.
  • Currently undergoing treatment for cancer
  • Had cardiovascular event in the past 60 days
  • Severe depression symptoms on PHQ-8 (total score ≥20)
  • Inpatient psychiatric treatment in the past 6 months
  • Eating disorder in past 5 years
  • Congestive heart failure resulting in recent (past 6 months) hospitalization or contributing to difficulty breathing or difficulty doing daily activities.
  • Dementia diagnosis
  • Bariatric surgery in the past year or currently undergoing evaluation for bariatric surgery
  • Currently taking doctor-prescribed medication for weight loss
  • Inability to stand on body weight scale independently
  • Impaired hearing
  • Unable to read content on websites without assistance
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
864 participants (estimated)

Study arms

  • Experimental
    MyHealthPath Tool

    Receive MyHealthPath Tool intervention.

    Behavioral: MyHealthPath Tool

  • Active comparator
    MyHealthPath Guide

    Receive MyHealthPath Guide intervention

    Behavioral: MyHealthPath Guide

Interventions

  • BehavioralMyHealthPath Tool

    Tailored, brief online tool to help patients learn about weight treatment options

  • BehavioralMyHealthPath Guide

    Informational material to help patients learn about weight treatment options

06

What researchers measure

Primary outcomes

  1. Proportion initiating treatment

    Attend at least one intervention session of comprehensive behavioral weight loss intervention. Documented by interventionist/program.

    Time frame: Within 2 months of PCP appointment date

Secondary outcomes

  1. Number of treatment sessions attended

    Total number of attended intervention session of comprehensive behavioral weight loss intervention. Documented by interventionist/program.

    Time frame: 6 months

  2. Proportion discussing weight-related topic with PCP

    Per patient self-report, discussed weight, diet, or physical activity with PCP at index PCP visit.

    Time frame: at completion of PCP visit (occuring up to 4 weeks after enrollment)

  3. Proportion achieving 5% weight loss

    Proportion of participants losing 5% of their baseline weight between baseline and 6 months

    Time frame: 6 months

  4. Percent weight loss

    Percent weight loss from baseline to 6 months

    Time frame: 6 months

07

Study locations

1 site
08

References and documents

Publications

  • McVay MA, Moore WS, Deceus D, Townsend SB, Rosenberg EI, Muenyi S, Lou X, Webb FJ, Diaz LD, Shankar MN, Ruiz J, Voils CI, Ross KM. A brief online tool to increase behavioral weight loss treatment initiation: Protocol for a cluster randomized trial. Contemp Clin Trials. 2025 Jul;154:107948. doi: 10.1016/j.cct.2025.107948. Epub 2025 May 15. PubMed 40381908 ↗

Individual participant data

Plan to share: Yes — De-identified individual data will be shared with other researchers. Researchers may need to complete a data use authorization agreement.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Analytic code

Time frame: Data will be available within one year of study completion and remain available indefinitely.

Access criteria: Access will be granted to researchers for any scientific purpose, including verifying/replicating analyses or conducting additional analyses, or

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2024 (actual). Primary completion is estimated for Apr 2028, 51 months after the start.

Of 3,697 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 51 months is above that.

Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 2, 2024
First posted
Jan 16, 2024
StartActual
Jan 24, 2024
Primary completionEst.
Apr 30, 2028
CompletionEst.
Jul 30, 2028
Last update
Aug 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06206954
Responsible party
Sponsor
First posted
Jan 16, 2024
Start date
Jan 24, 2024
Primary completion
Apr 30, 2028 (estimated)
Completion
Jul 30, 2028 (estimated)
Last update
Aug 6, 2026

Study contacts

Megan A McVay, PhD
principal investigator · University of Florida

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion